LA BioMed is committed to being at the forefront of translational biomedical research. The current recruitment initiative will enhance its multidisciplinary, trans-sectorial expertise by adding talented investigators who will synergize with its existing vibrant and interactive research groups in Cancer, Genomics, Health Services and Outcomes, Infection and Immunity, Metabolism and Endocrinology, Neurotherapeutics, and Respiratory Physiology and Medicine.
The successful applicant will receive a generous and competitive start-up package, office and laboratory space, and access to state of the art facilities including animal housing, genomics and bioinformatics, immunophenotyping and cell sorting, microscopy and molecular/cellular imaging, biostatistics and informatics, and molecular pathology. Institutional support also includes the potential for seed funding, access to two IRBs, an IACUC, and grant writing assistance as well as a pro-active Business Development office that facilitates the commercialization of discoveries. A newly-established bioscience incubator now exists on campus and an industrial park for biotechnology is being developed. LA BioMed is also a partner in the UCLA Clinical and Translational Science Institute.
Successful applicants will be proposed for in-residence academic appointments at the David Geffen School of Medicine at UCLA at the appropriate level. More information about the institute is available at https://labiomed.org
Applications consist of the following items, which should be communicated electronically to Dr. J. Madrenas, Chief Scientific Officer, c/o Ms. Arlene Lacayo at firstname.lastname@example.org :
1). A cover letter and Curriculum Vitae (combined into a single .pdf document); 2). Statement of Future Research Interests (2 pages maximum); 3). The names and contact information of three individuals who would provide letters of reference.
Review of applications will start on October 15, 2018, and will continue until the position is filled.